SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
- PMID: 32573469
- DOI: 10.1515/cclm-2020-0749
SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
Abstract
Objectives: The direct identification of SARS-CoV-2 RNA in nasopharyngeal swabs is recommended for diagnosing the novel COVID-19 disease. Pre-analytical determinants, such as sampling procedures, time and temperature storage conditions, might impact on the end result. Our aim was to evaluate the effects of sampling procedures, time and temperature of the primary nasopharyngeal swabs storage on real-time reverse-transcription polymerase chain reaction (rRT-PCR) results.
Methods: Each nasopharyngeal swab obtained from 10 hospitalized patients for COVID-19 was subdivided in 15 aliquots: five were kept at room temperature; five were refrigerated (+4 °C); five were immediately mixed with the extraction buffer and refrigerated at +4 °C. Every day and for 5 days, one aliquot per condition was analyzed (rRT-PCR) for SARS-CoV-2 gene E and RNaseP and threshold cycles (Ct) compared. To evaluate manual sampling, 70 nasopharyngeal swabs were sampled twice by two different operators and analyzed separately one from the other.
Results: A total of 6/10 swabs were SARS-CoV-2 positive. No significant time or storage-dependent variations were observed in SARS-CoV-2 Ct. Re-sampling of swabs with SARS-CoV-2 Ct lower than 33 resulted in highly reproducible results (CV=2.9%), while a high variability was observed when Ct values were higher than 33 (CV=10.3%).
Conclusions: This study demonstrates that time and temperature of nasopharyngeal swabs storage do not significantly impact on results reproducibility. However, swabs sampling is a critical step, and especially in case of low viral load, might be a potential source of diagnostic errors.
Keywords: COVID-19; SARS-CoV-2; nasopharyngeal swab; pre-analytical.
Comment in
-
Stability of SARS-CoV-2 respiratory samples in non-freezing condition: importance for tropical countries under heavy diagnostic demand.Clin Chem Lab Med. 2023 Jan 12;61(6):e78-e80. doi: 10.1515/cclm-2022-1221. Print 2023 May 25. Clin Chem Lab Med. 2023. PMID: 36628943 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous